Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Long-Term Deferred Tax (2021 - 2025)

Collegium Pharmaceutical has reported Long-Term Deferred Tax over the past 5 years, most recently at $112.5 million for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $112.5 million for Q4 2025, up 14.8% from a year ago — trailing twelve months through Dec 2025 was $112.5 million (up 14.8% YoY), and the annual figure for FY2025 was $112.5 million, up 14.8%.
  • Long-Term Deferred Tax for Q4 2025 was $112.5 million at Collegium Pharmaceutical, up from $102.5 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for COLL hit a ceiling of $112.5 million in Q4 2025 and a floor of $24.0 million in Q4 2022.
  • Median Long-Term Deferred Tax over the past 5 years was $34.2 million (2024), compared with a mean of $54.9 million.
  • Biggest five-year swings in Long-Term Deferred Tax: plummeted 69.31% in 2022 and later surged 273.33% in 2024.
  • Collegium Pharmaceutical's Long-Term Deferred Tax stood at $78.0 million in 2021, then plummeted by 69.31% to $24.0 million in 2022, then increased by 9.64% to $26.3 million in 2023, then surged by 273.33% to $98.0 million in 2024, then increased by 14.8% to $112.5 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $112.5 million (Q4 2025), $102.5 million (Q3 2025), and $92.0 million (Q2 2025) per Business Quant data.